4.6 Letter

Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

Kerry J. Welsh et al.

Summary: This study analyzed VAERS reports of thrombocytopenia after vaccination with Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine. The results showed a reporting rate of 0.80 per million doses for both vaccines, and the observed number of all thrombocytopenia cases following administration of mRNA COVID-19 vaccines is not greater than the number of ITP cases expected. Conclusion: The number of thrombocytopenia cases reported to VAERS does not suggest a safety concern attributable to mRNA COVID-19 vaccines at this time.

VACCINE (2021)

Letter Dermatology

Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines

Lacey B. Robinson et al.

JAMA DERMATOLOGY (2021)